Amarin Corp Plcuk (AMRN) Income from Continuing Operations (2010 - 2026)

Amarin Corp Plcuk (AMRN) posted quarterly Income from Continuing Operations of 10512000.0 for Q1 2026, up 33.03% YoY from 7901870.7 in Q1 2025, and down 758.82% sequentially from 1224000.0 in Q4 2025.

Amarin Corp Plcuk (AMRN) Income from Continuing Operations (2010 - 2026) Analysis & Trends

Amarin Corp Plcuk has disclosed Income from Continuing Operations across 17 years of filings, most recently posting 10512000.0 for Q1 2026.

  • In Q1 2026, Income from Continuing Operations rose 33.03% year-over-year to 10512000.0; the TTM figure through Mar 2026 stood at 33613000.0 (down 109.94% YoY), while the FY2025 annual figure was 38798000.0, down 277.89% from the prior year.
  • Income from Continuing Operations fell to 10512000.0 in Q1 2026, from 1224000.0 in the prior quarter.
  • Over the last five years, Income from Continuing Operations for AMRN reached as high as 110019000.0 in Q4 2022 and fell as low as 69956000.0 in Q2 2022.
  • The 5-year median for Income from Continuing Operations is 10512000.0 (2026), against an average of 6784058.82.
  • The widest YoY moves for Income from Continuing Operations: up 648.53% in 2022, down 1841.14% in 2022.
  • A 5-year view of Income from Continuing Operations shows it stood at 110019000.0 in 2022, then tumbled by 105.25% to 5781000.0 in 2023, then soared by 503.01% to 23298000.0 in 2024, then plunged by 105.25% to 1224000.0 in 2025, then tumbled by 758.82% to 10512000.0 in 2026.
  • According to Business Quant data, Income from Continuing Operations over the past three periods registered 10512000.0, 1224000.0, and 7738000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Income (Continuing) (Qtr)
1 Eli Lilly 1,066.16 Bn 1,060.88 Bn 16.22 Bn 7.40 Bn
2 Johnson & Johnson 611.69 Bn 589.64 Bn 15.96 Bn 5.24 Bn
3 AbbVie 444.34 Bn 434.99 Bn 10.78 Bn 697.00 Mn
4 Astrazeneca 284.94 Bn 277.05 Bn 12.61 Bn 833.00 Mn
5 Merck 224.23 Bn 218.58 Bn 12.09 Bn -4.21 Bn
6 Amgen 195.12 Bn 183.08 Bn 5.87 Bn 1.82 Bn
7 Gilead Sciences 156.45 Bn 148.73 Bn 5.52 Bn 2.02 Bn
8 Pfizer 136.01 Bn 123.24 Bn -1.21 Bn 2.71 Bn
9 Novartis Ag 113.45 Bn 113.67 Bn - -
10 Amarin Corp Plcuk 5.17 Bn 5.00 Bn 17.77 Mn -10.51 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -10.51 Mn
Dec 31, 2025 -1.22 Mn
Sep 30, 2025 -7.74 Mn
Jun 30, 2025 -14.14 Mn
Mar 31, 2025 -15.70 Mn
Dec 31, 2024 23.30 Mn
Sep 30, 2024 -25.13 Mn
Jun 30, 2024 1.52 Mn
Mar 31, 2024 -9.95 Mn
Dec 31, 2023 -5.78 Mn
Sep 30, 2023 -19.31 Mn
Jun 30, 2023 -17.56 Mn
Mar 31, 2023 -16.46 Mn
Dec 31, 2022 110.02 Mn
Sep 30, 2022 -5.14 Mn
Jun 30, 2022 -69.96 Mn
Mar 31, 2022 -31.56 Mn
Dec 31, 2021 14.70 Mn
Sep 30, 2021 -13.15 Mn
Jun 30, 2021 7.81 Mn